Learn more about whether Corcept Therapeutics Incorporated or Haleon plc is a better investment based on AAII's A+ Investor ...

Sei Investments Co. cut its stake in shares of Haleon plc (NYSE:HLN – Free Report) by 1.6% during the 4th quarter, Holdings ...

Haleon PLC closed 6.66% short of its 52-week high of £4.18, which the company reached on March 4th.

Commonwealth Equity Services LLC lessened its holdings in shares of Haleon plc (NYSE:HLN – Free Report) by 3.3% in the fourth ...

Haleon offers plenty of stability amidst the current market volatility, with its Power Brands driving strong organic growth.

Haleon PLC HLN shares slid 1.91% to £3.86 Monday, on what proved to be an all-around poor trading session for the stock ...

Wall Street's major averages closed in the green on Friday, and the benchmark S&P 500 (SP500) snapped a four-week losing streak after U.S. President Donald Trump said there might be some "flexibility" ...

In a report released on March 20, Karel Zoete from Kepler Capital maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price ...

Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...

Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's ...

Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors ...

Pfizer has finalized the sale of its entire holding in Haleon , generating approximately 2.5 billion ($3.24 billion), Reuters ...